Cargando…

Vaccination against SARS-CoV-2: a human enhancement story

BACKGROUND: Vaccination is an essential strategy for mitigating the COVID-19 pandemic. Besides its significance as a public health measure, vaccination is a sophisticated example of modern biotechnology. Since vaccination gives the human body an ability that it does not naturally possess, the questi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Döbler, Niklas Alexander, Carbon, Claus-Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642743/ https://www.ncbi.nlm.nih.gov/pubmed/34901462 http://dx.doi.org/10.1186/s41231-021-00104-2

Ejemplares similares

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
por: Cirillo, Nicola, et al.
Publicado: (2021)

A Game of Covid: Strategic Thoughts About a Ludified Pandemic
por: Raab, Marius Hans, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story – Authors' reply
por: Ozonoff, Al, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Neurological infection with SARS-CoV-2 — the story so far
por: Solomon, Tom
Publicado: (2021)

SARS-CoV-2 variants, a still unfinished story()
por: Pérez-Abeledo, M., et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

A Conversation Between Two Viruses: SARS-CoV and SARS-CoV-2 — Based on a True Story
por: Diamandis, Eleftherios P.
Publicado: (2020)

Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Cho, Hansam, et al.
Publicado: (2021)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Nucleic Acid Vaccines against SARS-CoV-2
por: Liu, Ying, et al.
Publicado: (2022)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

SARS-CoV-2 pirates the kidneys: A scar(y) story
por: Reiser, Jochen, et al.
Publicado: (2022)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
por: Alter, Galit, et al.
Publicado: (2021)

Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
por: Inserra, Felipe, et al.
Publicado: (2021)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
por: Weinberger, Birgit
Publicado: (2021)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

Progress and Prospects on Vaccine Development against SARS-CoV-2
por: Zhang, Jinyong, et al.
Publicado: (2020)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
por: Koch, Till, et al.
Publicado: (2021)

Decisive Conditions for Strategic Vaccination against SARS-CoV-2
por: Böttcher, Lucas, et al.
Publicado: (2021)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Targets and strategies for vaccine development against SARS-CoV-2
por: Malik, Jonaid Ahmad, et al.
Publicado: (2021)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

Optic neuromyelitis after vaccination against SARS-CoV-2
por: Hernandez-Vega, Melissa, et al.
Publicado: (2022)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gt76h8v4pgkhfqj2q081iqpiga